RE: EGYPT6 Jun 2021 19:47
Oriens , very poorly worded
I agree and most if not all were left astounded. I most certainly was , it was both foolish and unnecessary. However hopefully we will not see a repetition and I much prefer the RNS which informed the market of the forthcoming release of the LFT which they expected would generate significant revenue. Also believe although have absolutely no proof that they will be selling their Snpsig assays as fast as they can produce them. Furthermore as BH2 refocused us ,I am intrigued about the HT with 30% reduction in costs. We are all aware of the potential huge earnings from travel , so I am on balance more then ok to sit this out and await the outcome of the DHSC debacle. I see potential for huge growth over the next 12 months, but each must make their own decision.